Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog

Where and How to Find Co-Occurrences in Disease Biology Research

Posted on July 29th, 2016 by in Chemistry

In research, a co-occurrence refers to two linked concepts appearing within one sentence. In disease biology, a good example would be a sentence with facts that link a protein to a disease, biological functions or other proteins. Continue reading “Where and How to Find Co-Occurrences in Disease Biology Research” »

How Much Can Text-Mining Tools Achieve?

Posted on July 25th, 2016 by in Chemistry

Text mining has become an essential tool in the arsenal of disease biologists, medicinal chemists and other drug developers. There simply isn’t the time for a researcher to read all the relevant published literature to find answers— Continue reading “How Much Can Text-Mining Tools Achieve?” »

Qualification, Validation, and Fit-for-Purpose Biomarkers

Posted on July 22nd, 2016 by in Pharma R&D

As drug developers we rely greatly on biomarkers for providing information to our drug development programs and supporting submission to regulators.  Continue reading “Qualification, Validation, and Fit-for-Purpose Biomarkers” »

Precompetitive collaboration: Transforming innovation in drug discovery & development

Posted on July 21st, 2016 by in Pharma R&D

In 2013, Barbara Mittleman, former director of the Public-Private Partnership Program at the US National Institutes of Health and colleagues assessed the status of precompetitive consortia. Continue reading “Precompetitive collaboration: Transforming innovation in drug discovery & development” »

  1. 1
  2. 2
  3. 3